In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35099997.
- Also identified by DOI 10.7326/J21-0020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sholzberg M, Tang GH, Rahhal H, et al. <b>Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.</b> BMJ. 2021;375:n2400. 34649864.
Medical subject headings
- COVID-19
- Heparin